CLONING OF THE HUMAN GLYCINE TRANSPORTER TYPE-1 - MOLECULAR AND PHARMACOLOGICAL CHARACTERIZATION OF NOVEL ISOFORM VARIANTS AND CHROMOSOMAL LOCALIZATION OF THE GENE IN THE HUMAN AND MOUSE GENOMES
Km. Kim et al., CLONING OF THE HUMAN GLYCINE TRANSPORTER TYPE-1 - MOLECULAR AND PHARMACOLOGICAL CHARACTERIZATION OF NOVEL ISOFORM VARIANTS AND CHROMOSOMAL LOCALIZATION OF THE GENE IN THE HUMAN AND MOUSE GENOMES, Molecular pharmacology, 45(4), 1994, pp. 608-617
We report the molecular cloning of a cDNA encoding a high affinity hum
an glycine transporter. An open reading frame of 1914 nucleotides enco
des a 638-amino acid protein that transports glycine in a Na+/Cl--depe
ndent manner. In common with other Na+/Cl--dependent transporters, it
possesses 12 putative transmembrane domains, according to its hydropat
hicity profile. This protein is the human homologue of a glycine trans
porter previously isolated from rat [glycine transporter type 1b (GlyT
-1b)]. In addition to the human GlyT-1b, we also characterized a novel
functional isoform produced by alternative splicing. This isoform, Gl
yT-1c, which is distinct from GlyT-2 recently characterized in rat, co
ntains an additional exon encoding 54 amino acids in the amino-termina
l part of GlyT-1b and is mainly expressed in brain. These two isoforms
are products of the same gene and are localized on human chromosome 1
p31.3, as well as on mouse chromosome 4, close to the locus for the sp
ontaneous mouse neuromuscular mutation clasper. When expressed in COS-
7 cells, both the human GlyT-1b and GlyT-1c display a time- and dose-d
ependent uptake of glycine, which is abolished when either Na+ or Cl-
is substituted with other ions. For both GlyT-1b and GlyT-1c the affin
ities for glycine are similar, with K-m values of 70-90 mu M, and this
uptake is inhibited by sarcosine with similar potencies. In addition
to the three transporter isoforms present in the human genome, i.e., G
lyT-1a, GlyT-1b, and GlyT-1c, point-mutated variants, which appear to
be totally devoid of glycine uptake activity when expressed in COS-7 c
ells, were obtained by polymerase chain reaction amplification of mRNA
from human substantia nigra. These variants point to regions of the g
lycine transporter that might be important in the processing or transp
ort function of this protein.